Subscribe Us

header ads

Recents

header ads

Protein Engineering Market Size, Growth, Demands Outlook and Forecasts to 2032

According to the research report, the global protein engineering market size is expected to touch USD 15.25 Billion by 2032, from USD 3.18 Billion in 2022, growing with a significant CAGR of 16.97% from 2023 to 2032. 

Protein Engineering Market Size  2023 To 2032

The protein engineering report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global protein engineering in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global protein engineering market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global protein engineering during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/2767

Report Scope of the Protein Engineering Market:

Report CoverageDetails
Market Size in 2023USD 3.72 Billion
Market Size by 2032USD 15.25 Billion
Growth Rate from 2023 to 2032CAGR of 16.97%
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Product, By Technology, By Protein Type, and By End-User
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America and Middle East & Africa

This study covers a detailed segmentation of the global protein engineering market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global protein engineering market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Amgen, Inc.
  • Agilent Technologies
  • Bruker Cor.
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer, Inc.
  • Waters Corp.
  • Bio-Rad Laboratories
  • Merck KGaA
  • Danaher Corp.
  • GenScript Biotech Corp.

Market Segmentation

By Product

  • Instruments
  • Reagents
  • Software & Services

By Technology

  • Rational Protein Design
  • Directed Evolution
  • Hybrid Approach
  • De Novo Protein Design
  • Others

By Protein Type

  • Insulin
  • Monoclonal Antibodies 
  • Vaccines
  • Colony Stimulating Factor
  • Coagulation Factors
  • Other Proteins

By End-User 

  • Academic Research Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Research Methodology

The research methodology adopted by analysts for compiling the global protein engineering report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global protein engineering market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Protein Engineering Market 

5.1. COVID-19 Landscape: Protein Engineering Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Protein Engineering Market, By Product

8.1. Protein Engineering Market, by Product, 2023-2032

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Software & Services

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Protein Engineering Market, By Technology

9.1. Protein Engineering Market, by Technology, 2023-2032

9.1.1. Rational Protein Design

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Directed Evolution

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Hybrid Approach

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. De Novo Protein Design

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Protein Engineering Market, By Protein Type 

10.1. Protein Engineering Market, by Protein Type, 2023-2032

10.1.1. Others

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Monoclonal Antibodies

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Vaccines

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Colony Stimulating Factor

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Coagulation Factors

10.1.5.1. Market Revenue and Forecast (2020-2032)

10.1.6. Other Proteins

10.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Protein Engineering Market, By End-User

11.1. Protein Engineering Market, by April, 2023-2032

11.1.1. Academic Research Institutes

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Contract Research Organizations

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Pharmaceutical & Biotechnology Companies

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Protein Engineering Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Forecast, by Technology (2020-2032)

12.1.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.1.4. Market Revenue and Forecast, by End-User(2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End-User(2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End-User(2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.2.4. Market Revenue and Forecast, by End-User(2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End-User(2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End-User(2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End-User(2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End-User(2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.3.4. Market Revenue and Forecast, by End-User(2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End-User(2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End-User(2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End-User(2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End-User(2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.4.4. Market Revenue and Forecast, by End-User(2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End-User(2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End-User(2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End-User(2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End-User(2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.5.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.5.4. Market Revenue and Forecast, by End-User(2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End-User(2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Protein Type (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End-User(2020-2032)

Chapter 13. Company Profiles

13.1. Amgen, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Agilent Technologies

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Bruker Cor.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Thermo Fisher Scientific, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. PerkinElmer, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Waters Corp.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Bio-Rad Laboratories

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Merck KGaA

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Danaher Corp.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. GenScript Biotech Corp.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

 

Post a Comment

0 Comments